Page last updated: 2024-09-04

cvt 124 and Electrolytes

cvt 124 has been researched along with Electrolytes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abraham, WT; Beckman, E; Bennett, D; Bourge, R; Brater, DC; Dyer, F; Goldman, S; Gomez, M; Gottlieb, SS; Havranek, E; Thomas, I; Ticho, B	1

Trials

1 trial(s) available for cvt 124 and Electrolytes

Article	Year
BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation, 2002, Mar-19, Volume: 105, Issue:11 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Cross-Over Studies; Diuresis; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Electrolytes; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Purinergic P1 Receptor Antagonists; Sodium; Urinalysis; Xanthines	2002

Article

Year

BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.

Circulation, 2002, Mar-19, Volume: 105, Issue:11

Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Cross-Over Studies; Diuresis; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Electrolytes; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Purinergic P1 Receptor Antagonists; Sodium; Urinalysis; Xanthines

2002